ArticleBMJ open diabetes research & care2025
Metabolic factors moderate the association between hepatic fibrosis and atherosclerotic cardiovascular risk in type 2 diabetes.
Lusi Lu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.